| __timestamp | ACADIA Pharmaceuticals Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 9079000 |
| Thursday, January 1, 2015 | 90804000 | 20309000 |
| Friday, January 1, 2016 | 186456000 | 16945000 |
| Sunday, January 1, 2017 | 255062000 | 20559000 |
| Monday, January 1, 2018 | 265758000 | 29641000 |
| Tuesday, January 1, 2019 | 325638000 | 88258000 |
| Wednesday, January 1, 2020 | 388661000 | 162170000 |
| Friday, January 1, 2021 | 396028000 | 167218000 |
| Saturday, January 1, 2022 | 369090000 | 239528000 |
| Sunday, January 1, 2023 | 402466000 | 94252000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing operational expenses is crucial for success. Over the past decade, ACADIA Pharmaceuticals Inc. and Galapagos NV have demonstrated contrasting strategies in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023, reflecting their aggressive expansion and market penetration efforts. In contrast, Galapagos NV maintained a more conservative approach, with a modest increase of around 940% over the same period. This divergence highlights ACADIA's focus on rapid growth, while Galapagos NV appears to prioritize steady, sustainable development. As investors and industry analysts evaluate these companies, understanding their SG&A efficiency provides valuable insights into their strategic priorities and potential future performance.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights